Xanthones: The Antioxidant Compounds Behind Mangosteen's Health Benefits

How the xanthones in mangosteen's deep purple rind fight inflammation, support cardiovascular health, and show anticancer potential

Mangosteen is a tropical fruit native to Southeast Asia, prized for its sweet-tart flesh and its intensely purple rind. That rind is where the real medicine lives: it's packed with a class of polyphenols called xanthones — particularly alpha-mangostin — that are among the most potent antioxidants found in any food. Research has confirmed that these xanthones are absorbed into the human bloodstream when the fruit or its juice is consumed [1]. They work against inflammation, oxidative stress, and in laboratory studies, have shown striking effects against cancer cells [4]. Mangosteen has been used in traditional Southeast Asian medicine for centuries, and modern science is catching up to why.

What Xanthones Are and How They Work

Xanthones are tricyclic aromatic compounds found in only a handful of plants, with mangosteen's rind being one of the richest known sources. The main active xanthone is alpha-mangostin, though the rind contains over 60 different xanthone variants including beta-mangostin, gamma-mangostin, and garcinone C.

These molecules are powerful for two reasons: their chemical structure makes them highly effective at neutralizing free radicals (reactive oxygen species), and they interact with multiple cell signaling pathways simultaneously — giving them a broader biological footprint than most single compounds.

Anti-Inflammatory Action

Alpha-mangostin suppresses inflammation through several converging mechanisms:

NF-κB inhibition: NF-κB is the master regulator of the inflammatory response. Alpha-mangostin blocks its activation, reducing production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 [2]. This is the same pathway targeted by many pharmaceutical anti-inflammatories.
COX-2 suppression: Cyclooxygenase-2 is the enzyme responsible for producing prostaglandins — the signaling molecules that drive pain, swelling, and fever. Alpha-mangostin reduces COX-2 expression in a manner similar to NSAIDs but without the same gastric side effects in animal models.
Reduced oxidative stress: Chronic inflammation and oxidative stress amplify each other. By quenching reactive oxygen species, xanthones dampen the oxidative stress that would otherwise keep NF-κB and COX-2 activated.

In an animal study of collagen-induced arthritis (a well-validated model of rheumatoid arthritis), alpha-mangostin significantly reduced joint inflammation, cartilage destruction, and inflammatory markers. The effects were seen at doses that translated to feasible human equivalents [3].

Antioxidant Properties

Mangosteen rind contains multiple antioxidant compound types — xanthones, polysaccharides, and phenolic acids — and they appear to work synergistically. A 2024 study examining the antioxidant activity of mangosteen rind polysaccharides found significant free radical scavenging activity, adding to the antioxidant profile beyond the xanthones alone [5].

In terms of ORAC (oxygen radical absorbance capacity) — one standard measure of antioxidant power — mangosteen rind extracts score extremely high, generally well above blueberries, pomegranate, and acai on a per-gram basis. However, ORAC values don't directly translate to in-body efficacy; what matters more is whether the compounds are absorbed.

Bioavailability: What Actually Gets In

Unlike many plant antioxidants that are poorly absorbed, xanthones from mangosteen juice were measurable in plasma of healthy human subjects [1]. After consuming a mangosteen beverage, alpha-mangostin and its metabolite (a glucuronide conjugate) appeared in blood within 2–4 hours. This confirms that xanthones cross the gut wall and enter systemic circulation — a critical but often unconfirmed step in evaluating plant compounds.

In cell culture studies using human intestinal cells, alpha-mangostin was taken up efficiently and its anti-inflammatory activity was maintained even after cellular metabolism [2]. The conjugated form (glucuronide) retained partial activity, which is relevant because most polyphenols are extensively conjugated before reaching target tissues.

Anticancer Potential

Laboratory evidence for mangosteen's anticancer effects is extensive, though it is important to be clear: the vast majority of this research is in cell lines and animal models, not human clinical trials.

A comprehensive 2022 review catalogued the evidence [4]:

Apoptosis induction: Alpha-mangostin triggers programmed cell death in multiple cancer cell lines including breast, colon, prostate, and liver cancer. The primary mechanism is mitochondrial — it disrupts the mitochondrial membrane potential, activating intrinsic apoptosis pathways.
Cell cycle arrest: Xanthones halt cancer cells at the G1 phase of the cell cycle, preventing replication.
Anti-angiogenesis: In animal models, mangosteen extracts inhibit formation of new blood vessels into tumor tissue (angiogenesis), which tumors require to grow beyond a small size.
Synergy with chemotherapy: In several cell line studies, alpha-mangostin enhanced the efficacy of conventional chemotherapy drugs including cisplatin and doxorubicin, potentially allowing lower doses.

None of this constitutes proof that eating mangosteen treats or prevents cancer in humans. The doses used in cell studies are often higher than what dietary consumption would achieve. However, the mechanistic evidence is strong enough that researchers consider it worth investigating in human trials.

Practical Use

Whole fruit: The edible white flesh of the mangosteen contains some xanthones but far less than the rind. Traditional preparations use the rind as a tea or decoction.

Juice products: Many commercial mangosteen products use the whole fruit — rind included — processed into a juice concentrate. The bioavailability study [1] used a commercial mangosteen juice product, so absorption data applies to this form.

Supplements: Standardized mangosteen rind extracts in capsule form are available, typically standardized to alpha-mangostin content (often 5–10% or higher). Doses used in studies range from 200–500 mg of extract.

Frozen or dried rind: In Southeast Asian herbal medicine, the dried rind is used in teas. This is a traditional preparation but with less standardization than commercial extracts.

Cautions:

No established safe upper limit for supplemental doses in humans
May interact with anticoagulant medications (some xanthones affect platelet function)
Rind-based products should be avoided during pregnancy until more safety data exists
The fruit flesh is low in the active compounds; rind-containing products are needed for therapeutic benefit

See our quercetin page and pomegranate page for related polyphenol antioxidants with comparable anti-inflammatory profiles.

Evidence Review

Bioavailability in Humans: Chitchumroonchokchai et al. 2012

The fundamental question for any dietary compound is whether it actually gets absorbed. Chitchumroonchokchai et al. (PMID 22399525, Journal of Nutrition, 2012) addressed this directly with a human pharmacokinetic study. Healthy adults consumed a commercially available mangosteen juice product, and plasma was collected at multiple time points over 24 hours. Alpha-mangostin was detected in all participants, appearing in plasma within 2–4 hours post-ingestion and peaking at approximately 4–6 hours. A glucuronide conjugate of alpha-mangostin — a metabolic product — was also detected. This study established that xanthones cross the intestinal barrier in humans, which is a prerequisite for any systemic benefit. Crucially, the study used a real commercial product at achievable doses rather than isolated compounds at supraphysiological concentrations, strengthening its relevance to dietary use.

Anti-inflammatory Activity in Human Cells: Gutierrez-Orozco et al. 2013

Gutierrez-Orozco et al. (PMID 23578285, Journal of Agricultural and Food Chemistry, 2013) built on the bioavailability work by exposing human macrophage-like cells (THP-1) to alpha-mangostin and its metabolites at concentrations relevant to those observed in plasma after consumption. Both the parent compound and its glucuronide metabolite reduced LPS-stimulated secretion of TNF-α and IL-6 — two key pro-inflammatory cytokines. Importantly, anti-inflammatory activity was measured at concentrations comparable to what the prior bioavailability study showed could be achieved in human plasma, bridging the gap between cell studies and physiological relevance. The study also confirmed uptake of alpha-mangostin by macrophages, suggesting direct cellular action in immune cells.

Arthritis Model: Herrera-Aco et al. 2019

Herrera-Aco et al. (PMID 30557668, Food and Chemical Toxicology, 2019) used a collagen-induced arthritis model in DBA/1J mice — the standard preclinical model for rheumatoid arthritis — to evaluate alpha-mangostin's effects on established disease rather than prevention. Mice were treated with alpha-mangostin after arthritis was already induced, making this therapeutically relevant. Treatment significantly reduced clinical arthritis scores, paw edema, and histological joint damage. Plasma and tissue levels of TNF-α, IL-1β, and IL-17 were significantly reduced. Antioxidant enzymes (superoxide dismutase, catalase) were upregulated in treated animals, supporting the dual anti-inflammatory/antioxidant mechanism. The effective doses in this mouse study, when translated by body surface area to human equivalents, correspond to roughly 200–400 mg/day of alpha-mangostin — in the range of commercially available standardized extracts.

Anticancer Review: Nauman and Johnson 2022

Nauman and Johnson (PMID 34896543, Pharmacological Research, 2022) systematically reviewed the anticancer evidence for mangosteen xanthones published through 2021. They catalogued studies across more than 20 cancer cell types and multiple animal tumor models. Their key findings:

Strongest evidence exists for breast, colorectal, and prostate cancer lines, where consistent pro-apoptotic and anti-proliferative effects have been replicated by multiple independent research groups using different cell lines and methodologies.
Mechanisms: The most consistently documented mechanisms are mitochondrial-mediated apoptosis (Bcl-2/Bax pathway), G1 cell cycle arrest via cyclin D1/CDK4 inhibition, and activation of caspase-3 and caspase-9.
Combination effects: Several studies showed synergistic effects with cisplatin, 5-fluorouracil, and doxorubicin at sub-toxic concentrations. This has generated interest in xanthones as potential adjuncts in chemotherapy regimens.
Limitations: The authors note that no human clinical trials of mangosteen for cancer treatment or prevention have been completed. Most studies use isolated alpha-mangostin at concentrations unlikely to be achieved through diet alone. Bioavailability, in vivo stability, and tumor microenvironment penetration remain active areas of investigation.

Antioxidant Polysaccharides: Tang and Huang 2024

Tang and Huang (PMID 39054446, BMC Complementary Medicine and Therapeutics, 2024) investigated the antioxidant activity of polysaccharides isolated from the mangosteen rind — a separate compound class from the xanthones. Using multiple antioxidant assays (DPPH, ABTS, hydroxyl radical scavenging), the polysaccharides demonstrated significant free radical quenching activity. Modified derivatives (carboxymethylated and sulfated polysaccharides) showed enhanced antioxidant activity compared to the parent polysaccharides. This study adds a layer of complexity to mangosteen's antioxidant profile: the rind contains multiple independent antioxidant compound classes that may act additively or synergistically when consumed together in whole-fruit preparations.

Evidence Strength Assessment

Human bioavailability: Confirmed (one pharmacokinetic study in healthy adults). Moderate quality; needs replication with dose-ranging data.

Anti-inflammatory effects: Strong mechanistic evidence across multiple pathways; demonstrated in human cells at physiologically relevant concentrations; robust animal model data. No human clinical trials powered for clinical outcomes.

Antioxidant activity: Well-established in laboratory assays; confirmed absorption of active compounds in humans.

Anticancer properties: Extensive in vitro and animal evidence; promising mechanistic data; no human clinical trials. The gap between cell culture findings and clinical benefit is large and unresolved.

Overall rating: Mangosteen xanthones represent genuinely promising compounds with solid mechanistic and preclinical evidence. Human evidence is currently limited to bioavailability and cell-level anti-inflammatory studies. The traditional use as an anti-inflammatory agent in Southeast Asian medicine is supported by the science. Claims of cancer treatment or prevention in humans are premature based on current evidence.

References

Xanthones from mangosteen juice are absorbed and partially conjugated by healthy adultsChitchumroonchokchai C, Riedl KM, Suksumrarn S, Clinton SK, Kinghorn AD, Failla ML. Journal of Nutrition, 2012. PubMed 22399525 →
Anti-inflammatory activity and metabolism of alpha-mangostin in human cellsGutierrez-Orozco F, Chitchumroonchokchai C, Lesinski GB, Suksamrarn S, Failla ML. Journal of Agricultural and Food Chemistry, 2013. PubMed 23578285 →
Anti-inflammatory and antioxidant effects of alpha-mangostin on collagen-induced arthritis in miceHerrera-Aco DR, Medina-Campos ON, Pedraza-Chaverri J, Sciutto-Conde E, Fragoso-Gonzalez G. Food and Chemical Toxicology, 2019. PubMed 30557668 →
The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones in 2021Nauman MC, Johnson JJ. Pharmacological Research, 2022. PubMed 34896543 →
Antioxidant activity of polysaccharides from Garcinia mangostana rind and their derivativesTang Z, Huang G. BMC Complementary Medicine and Therapeutics, 2024. PubMed 39054446 →